Article Information
History
- December 13, 2020.
Article Versions
- Version 1 (September 22, 2020 - 04:00).
- Version 2 (September 22, 2020 - 14:39).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kylie P Glanville1,*,
- Jonathan R I Coleman1,2,
- David M Howard1,3,
- Oliver Pain1,2,
- Ken B Hanscombe1,2,
- Bradley Jermy1,2,
- Ryan Arathimos1,2,
- Christopher Hübel1,2,
- Gerome Breen1,2,
- Paul F O’Reilly1,4 and
- Cathryn M Lewis1,2,5
- 1Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
- 2NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, King’s College London, London, UK
- 3Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
- 4Genetics and Genomic Sciences, Icahn School of Medicine, Mount Sinai, New York, NY, US
- 5Department of Medical & Molecular Genetics, King’s College London, London, UK
- ↵*Address correspondence to
Kylie P. Glanville, kylie.glanville{at}kcl.ac.uk; Social, Genetic and Developmental Psychiatry Centre; Institute of Psychiatry, Psychology & Neuroscience; King’s College London, de Crespigny Park, London SE5 8AF; UK.
Posted December 13, 2020.
Multiple measures of depression to enhance validity of Major Depressive Disorder in the UK Biobank
